Legend:
CC = Vancouver Convention Centre
F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
|
|
|
|
468 * !
|
Wed, 8/1/2018,
8:30 AM -
10:20 AM
|
CC-West 120
|
|
Blinded Data Reviews Are Necessary in Today's Clinical Trials — Topic Contributed Papers
|
|
Biopharmaceutical Section
|
|
Organizer(s): Ibrahim Turkoz, Janssen Research and Development, LLC
|
|
Chair(s): Ibrahim Turkoz, Janssen Research and Development, LLC
|
|
8:35 AM
|
Predicting the Timing of the Final Event by Fitting B Splines to Poisson Intensity Rates
Marcus Sobel, Temple Universisity; Ibrahim Turkoz, Janssen Research and Development, LLC
|
|
8:55 AM
|
Estimating Event Rate Differences Using Data from Blinded Trials
A. Gould, Merck Research Laboratories; Bill Wang, Merck
|
|
9:15 AM
|
Bayesian Blinded Sample Size Adjustment for Risk Differences
Andrew Hartley, PPD, Inc.
|
|
9:35 AM
|
Blinded vs. Unblinded Sample Size Re-Estimation: When and What?
Yili Pritchett, MedImmune
|
|
9:55 AM
|
Tools and Techniques for Blinded Data Reviews in Ongoing Clinical Trials
Suresh Ankolekar, Cytel Inc.; Hrishikesh Kulkarni, Cytel Inc.
|
|
10:15 AM
|
Floor Discussion
|
